Literature DB >> 17389257

Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance.

Joël Girouard1, Yves Giguère, Jean-Marie Moutquin, Jean-Claude Forest.   

Abstract

Insulin resistance syndrome has been observed in women with hypertensive disease of pregnancy, but few studies evaluated the presence of the syndrome a few years after delivery. The objective of this study was to evaluate the presence of insulin resistance and its metabolic alterations in these women compared with those who had a normal pregnancy. We performed an observational study in 168 women with previous hypertensive disease of pregnancy and 168 control subjects with normal pregnancy contacted, on average, 7.8 years after their first delivery (mean age: 34.8 years). Complete blood lipid profile, insulin, glucose, homocysteine, adipokins, and markers of inflammation were measured. Also, an oral glucose tolerance test was performed in 146 case and 135 control subjects. Case subjects were more overweight compared with control subjects. We found significantly lower high-density lipoprotein cholesterol and adiponectin levels and higher apolipoprotein (apo) apoB/apoA1 ratio, homocysteine, leptin, and insulin levels among case subjects compared with control subjects (P<or=0.004). Also, case subjects were more insulin resistant in the basal state estimated by homeostasis assessment model 2, as well as in the nonbasal state as estimated by insulin sensitivity indices calculated from the oral glucose tolerance test. Finally, in a multivariate regression model, leptin, apoB/apoA1 ratio, waist circumference, adiponectin, and free fatty acids explained 40% of homeostasis assessment model 2 variance. Young women with previous hypertensive disease of pregnancy show signs of insulin resistance within the first decade after delivery. These findings suggest that insulin resistance may be the link between hypertensive disease of pregnancy and increased cardiovascular risk later in life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389257     DOI: 10.1161/HYPERTENSIONAHA.107.087528

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

1.  Hypertension in pregnancy is associated with elevated C-reactive protein levels later in life.

Authors:  Catherine M Brown; Stephen T Turner; Kent R Bailey; Thomas H Mosley; Sharon L R Kardia; Heather J Wiste; Iftikhar J Kullo; Vesna D Garovic
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

Review 2.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 3.  Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.

Authors:  Carolina Valdiviezo; Vesna D Garovic; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

4.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

5.  Long-term Recall of Time to Pregnancy.

Authors:  Anne Marie Z Jukic; D Robert McConnaughey; Clarice R Weinberg; Allen J Wilcox; Donna D Baird
Journal:  Epidemiology       Date:  2016-09       Impact factor: 4.822

6.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

Review 7.  Maternal preeclampsia and risk for cardiovascular disease in offspring.

Authors:  Guadalupe Herrera-Garcia; Stephen Contag
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

8.  Retinol binding protein 4--a novel association with early-onset preeclampsia.

Authors:  Edi Vaisbuch; Roberto Romero; Shali Mazaki-Tovi; Offer Erez; Sun Kwon Kim; Tinnakorn Chaiworapongsa; Francesca Gotsch; Nandor Gabor Than; Zhong Dong; Percy Pacora; Ronald Lamont; Lami Yeo; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

9.  Maternal serum adiponectin multimers in gestational diabetes.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

10.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.